PrEP on Trial: the Future of HIV in Indonesian Policy Worlds
In 2012, the first pre-exposure prophylaxis (PrEP) drugs, billed as a pill a day to prevent HIV, were authorized for use in the United States. Heralded as a…
In 2012, the first pre-exposure prophylaxis (PrEP) drugs, billed as a pill a day to prevent HIV, were authorized for use in the United States. Heralded as a…
The introduction of effective combination antiretroviral therapy for HIV disease in 1996 was commonly narrated as a major event that transformed HIV from an inevitable death sentence into…
Recently, physicians, public health experts, and anthropologists (among others) have pointed to a prevalence of gender, class, race, age, and ethnic bias in biomedical research and the specific…
The sleep experiment, back in Chicago in 1992… was that really more than 25 years ago? In that experiment he could locate the seed of what would become…
This month saw breaking news web-wide on one aspect of medicine that has drawn critiques and support from both social scientists and biomedical experts: clinical trials. Drug trials…